No Data
Rakovina Therapeutics to Present Research Highlighting Small-Molecule Bifunctional Inhibitors of PARP1/2 and HDAC Enzymes at the 36th EORTC-NCI-AACR Symposium in Barcelona Spain
Rakovina Therapeutics Announces Initial Drug Candidates From Deep Docking AI Molecule Discovery Platform
Rakovina Therapeutics and Variational AI Announce Drug Discovery Collaboration
Rakovina Therapeutics Second-Quarter Loss Widens on Higher Spending
Rakovina Therapeutics Announces 2024 Q2 Financial Results and Provides Corporate Update
Rakovina Therapeutics Raises $2 Million in Oversubscribed Private Placement
No Data